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Background: Whilst there have been studies on the risks and outcomes of MRSA colonization and infections in
HIV-positive patients, local data is limited on the risk factors for MRSA colonization among these patients. We
undertook this study in a tertiary HIV care centre to document the risk factors for colonization and to determine the
prevalence of MRSA colonization among HIV-positive outpatients in Singapore.
Methods: This was a cross-sectional study in which factors associated with MRSA positivity among patients with
HIV infection were evaluated. A set of standardized questionnaire and data collection forms were available to
interview all recruited patients. Following the interview, trained nurses collected swabs from the anterior
nares/axilla/groin (NAG), throat and peri-anal regions. Information on demographics, clinical history, laboratory
results and hospitalization history were retrieved from medical records.
Results: MRSA was detected in swab cultures from at least 1 site in 15 patients (5.1%). Inclusion of throat and/or
peri-anal swabs increased the sensitivity of NAG screening by 20%. Predictors for MRSA colonization among
HIV-positive patients were age, history of pneumonia, lymphoma, presence of a percutaneous device within the
past 12 months, history of household members hospitalized more than two times within the past 12 months, and a
most recent CD4 count less than 200.
Conclusions: This study highlights that a proportion of MRSA carriers would have been undetected without
multiple-site screening cultures. This study could shed insight into identifying patients at risk of MRSA colonization
upon hospital visit and this may suggest that a risk factor-based approach for MRSA surveillance focusing on high
risk populations could be considered.
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Methicillin-resistant Staphylococcus auerus (MRSA)
infections present a significant burden in terms of mor-
bidity, length of hospitalization, and rising healthcare
costs [1-3]. Studies have shown that staphylococcal
colonization is a predominant risk factor for subsequent
infection, and nasal carriage of Staphylococcus aureus
increases the risk of subsequent infection two- to
twelve-fold, especially during hospitalization [4-7]. Risk
factors associated with MRSA colonization include* Correspondence: mar_kyaw_win@ttsh.com.sg
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reproduction in any medium, provided the orfrequent exposure to healthcare settings, previous MRSA
infections, and frequent antibiotic usage [8-13].
HIV-positive patients are at higher risk of MRSA
colonization associated with frequent exposure to
healthcare facilities, frequent oral antibiotic intake, low
CD4 count, and other behavioral risk factors [13-15].
HIV has been recognized as an independent risk factor
for colonization with MRSA [16], and S. aureus infec-
tions are known to be responsible for substantial mor-
bidity and mortality in HIV-positive patients [17,18].
Whilst there have been studies on the risks and out-
comes of MRSA colonization in HIV-positive patients,
local data is limited on the risk factors for MRSA
colonization among these patients. We undertook thistd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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factors for colonization and to determine the prevalence
of MRSA colonization among HIV-positive outpatients.
Methods
Study type and study population
This was a cross-sectional study in which factors asso-
ciated with MRSA positivity among patients with HIV
infection were evaluated. The study was done at the
Communicable Disease Centre (CDC) at Tan Tock Seng
Hospital (TTSH), the national referral centre for HIV.
CDC is administratively responsible to TTSH, the sec-
ond largest general hospital in Singapore, with
1,200beds. All HIV-positive patients who attended the
specialist outpatient clinic at CDC between 12th Novem-
ber and 1st December 2008 were asked to participate.
Verbal consent was obtained from all participants.
Data sources and data collection
A set of standardized questionnaire and data collection
forms were available to interview all recruited patients.
Information collected include visits to a healthcare facil-
ity in the past 12 months, contact with healthcare work-
ers (HCW) in the past 6 months, hospitalization history
of household members, presence of a percutaneous de-
vice in the past 12 months or urinary catheter in the
past 6 months; surgery in the past 12 months, and use
of intravenous and oral antibiotics in the past 1 month
and 3 months, respectively. This information was col-
lected through interviews by a research staff.
Following the interview, trained nurses collected swabs
from the anterior nares, axilla, groin, throat, and peri-
anal regions. The first three areas were swabbed using a
single swab stick. Separate swab sticks were used for the
throat and peri-anal region. Samples were inoculated on
chromogenic agar plates (MRSASelect, BioRad, France)
and incubated at 37°C for 18–28 hours. Growth of pink
or mauve colonies was read as MRSA positive, while col-
orless colonies were MRSA negative.
Information on demographics, clinical history, labora-
tory results and hospitalization history were retrieved
from medical records. These included the presence ofTable 1 Sites of Methicillin-resistant Staphylococcus
aureus (MRSA) colonization




NAG + Throat 2
NAG + Peri-anal 1
NAG + Throat + Peri-anal 3
NAG = Nares, axilla, groin.co-morbidities, admission to intensive care unit or gen-
eral hospitalization in the past 12 months, use of anti-
retroviral (ART) therapy during the preceding 12
months, and current usage of co-trimoxazole and beta
lactam antibiotics in the past six months. The most re-
cent CD4 count during the preceding 6 months and pre-
vious MRSA colonization history were also collected.
Statistical analysis
For this prospective case control study, cases were
defined as HIV-positive patients with laboratory-
confirmed MRSA colonization, and controls as HIV-
positive patients without laboratory-confirmed MRSA
colonization within the study period.
Cases and controls were compared by univariate ana-
lysis to determine differences in the allocation of poten-
tial risk factors. Descriptive statistics were used to
describe the distribution of the variables in the study
population. A chi square test or Fisher’s exact test was
used to evaluate differences in categorical variables.
Crude odds ratios for continuous variables were
obtained by using logistic regression. All variables with
p<0.05 in univariate analysis were included in multivari-
ate analysis to identify independent risk factors of
MRSA. A stepwise logistic regression model was used to
select variables for inclusion in the final model. Variables
with collinearity were not simultaneously considered in
the final model.
Study approval
This study was approved by the domain specific review
board (DSRB) of the National Healthcare Group, Singa-
pore (DSRB Reference No. 2009/00545).
Results
Descriptive statistics and univariate analysis
A total of 296 HIV-positive patients were recruited, giv-
ing us a response rate of 93%. They were predominantly
male (n=257, 86.8%), and the median age of these
patients was 43 years (range, 18–73). Among the 296
patients, MRSA was detected in swab cultures from at
least 1 site in 15 patients (5.1%). Out of these 15
patients, 6 had positive MRSA cultures from their nasal/
axilla/groin swab only while 3 were positive in either
throat or peri-anal swabs only (Table 1). The demo-
graphic characteristics of the 15 cases and 281 controls
are shown in Table 2. There was a slight male predomin-
ance among the case patients; males were 2.2 times
more likely than females to have MRSA.
Significant HIV-associated conditions among cases
included Pneumocystis jiroveci pneumonia (PCP) and
bacterial pneumonia. Patients with PCP were more likely
to have MRSA than those without (odds ratio [OR], 3.3;
95%CI, 1.14-9.30); those with bacterial pneumonia were
Table 2 Risk factors for MRSA colonization: Univariate analysis
Vañable MRSA Position n (%)* MRSA Negatve n (%)* OR (95% CI) P value
Demographics
Age(median, range), years 50 (30–67) 43 (18–73) 1.1 (1.00-1.11) 0.036
Age>=65 1 (6.7) 7 (2.5) 2.8 (0.32-24.32) 0.352
Gender, Male 14 (933) 243 (86.5) 2.2 (0.28-17.13) 0.455
AIDS-related infections
Tuberculosis 3 (20.0) 46 (16.4) 1.3 (0.35-4.71) 0.713
Pneumoncystic jiroveci pneumonia 8 (53.3) 73 (26.0) 3.3 (1.14-9.30) 0.027
Bacterial Pneumonia 4 (26.7) 24 (8.5) 3.9 (1.15-13.17) 0.029
Cytomegalovirus infection 3 (20.0) 25 (8.9) 2.6 (0.68-9.68) 0.166
Skinlesion 6 (40.0) 70 (24.9) 2.0 (0.69-5.85) 0.200
Lymphoma 3 (20.0) 4 (1.4) 17.3 (3.48-86.15) <0.001
Toxoplasmosis 1 (6.7) 6 (2.1) 3.3 (0.37-29.08) 0.287
Exposure to Health Facilities
Prior hospitalization in the past one year 9 (60) 44 (15.7) 81 (274–23.84) <0.001
Outpatient visit to CDC in the past one year 15 (100) 259 (92.2) NC 0.260
Admission to Intensive care unit in the past one year 1 (6.7) 1 (0.4) 20.0 (1.19-336.64) 0.038
Polyclinic visit in the past one year* * 7 (46.7) 125 (44.5) 1.1 (0.39-3.09) 0.870
Surgery in the past one year* * 1 (6.7) 11 (3.9) 1.8 (0.21-14.55) 0.603
Presence of Percutaneous Device in the past one year* * 11 (73.3) 47 (16.7) 13.7 (4.18-44.84 <0.001
Urinary catheterization in the past six months* * 1 (6.7) 4 (1.4) 5.0 (0.52-47.22) 0.165
Household member hospitalized
more than two times in the past one year * *
5 (33.3) 28 (10.0) 4.5 (1.44-14.16) 0.010
Patient contact with a health care
worker in the past 6 month * *
5 (33.3) 29 (10.3) 4.3 (l.39-13.59) 0.012
Drug history
Recent intravenous antibiotic usage 8 (72.7) 37 (78.7) 0.7 (0.16-3.23) 0.669
Oral antibiotic usage in the past three months 11 (73.3) 96 (34.2) 5.3 (1.64-17.09) 0.005
On antiretroviral therapy in the preceding one year 14 (93.3) 238 (84.7) 2.5 (0.32-17.74) 0.376
Current use of Co-trimoxazole 4 (26.7) 77 (27.4) 1.0 (0.29-3.12) 0.950
Beta lactam antibiotic usage in the past six months 5 (33.3) 10 (3.6) 13.6 (3.90-47.07) <0.001
Others
History of previous MRSA colonization 2 (13.3) 7 (2.5) 6.0 (1.14-31.89) 0.035
Most recent CD4<20O 9 (60) 71 (25.3) 4.4 (1.53-12.90) 0.006
*Unless otherwise indicated.
* * Data collected by questionnaire.
NC = not calculable.
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13.17). Patients with lymphoma were 17.3 times more
likely than patients without lymphoma to be colonized
with MRSA (95%CI, 3.48-86.15).
Among MRSA positive patients, 9 (60%) had prior
hospitalization in the past year compared with 44
(15.7%) of the MRSA negative controls. HIV-positive
patients who had outpatient visit(s) to CDC or a poly-
clinic within the past year were more likely to be colo-
nized with MRSA compared to those who did not.However, this was not statistically significant. Addition-
ally, those who had a percutaneous device in the past 12
months, a history of household members hospitalized
more than two times in the past 12 months, or contact
with a health care worker in a hospital in the past 6
months were significantly more likely to have MRSA
than patients without these exposures (Table 2).
Risk factors relating to drug exposure were also evalu-
ated in Table 2. Patients with oral antibiotic use during
the last 3 months were 5.3 times more likely than
Table 3 Independent Risk Factors Associated with MRSA
colonization: Multivariate analysis
Expore OR (95% CI) P value
Lymphoma 15.7 (2.0-123.10) 0.009
Most recent CD4<200 9.1 (1.187-44.53) 0.006
Hoousehold member
hospitalized more than
two times in the past one year
8.4 (1.80-39.18) 0.007
Presence of Percutaneous
Device in the past one year
8.1 (2.07-31.81) 0.003
Pneumonia 6.5 (1.30-32.55) 0.023
Age (years) 1.1 (1.01-1.13) 0.033
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MRSA (73.3% vs. 34.2%; 95%CI, 1.64-17.09). In addition,
patients who used beta lactam antibiotics within the last
6 months were also more likely to be cases than patients
who did not. Patients with a recent CD4 count less than
200 were 4.4 times more likely than patients with a re-
cent CD4 greater than 200 to be cases than controls.Multivariate analysis
Upon multivariate analysis, predictors for MRSA
colonization among HIV-positive patients were age, his-
tory of bacterial pneumonia, lymphoma, presence of a
percutaneous device within the past 12 months, history
of household members hospitalized more than two times
within the past 12 months, and a most recent CD4
count less than 200 (Table 3). We generated a receiver
operating characteristic (ROC) curve to evaluate the
final logistic regression model. The area under the ROC
curve (AUC) was 0.89 (95% CI, 0.83-0.97).Discussion
Singapore first isolated MRSA in the early 1980s [19].
The incidence and prevalence of MRSA infections have
remained steady during the last two decades in major
academic medical centers, although methicillin resist-
ance appeared in 35% of all S. aureus isolates in one
study [20]. The incidence of HIV infection in Singapore
has increased rapidly over the last decade [21].
A previous study at CDC showed that the prevalence
of MRSA colonization in HIV-positive outpatients was
higher than the prevalence of MRSA colonization in
other populations [15]. A study by Villacian et al. using
only nasal swab reported a lower point prevalence of
MRSA colonization (3% vs. 5.1% in our study) and 20%
colonization with methicillin-sensitive Staphylococcus
aureus (MSSA) [15]. Most studies and screening pro-
grams evaluating the prevalence of MRSA colonization
have utilized swabs from the nares, axilla and groin
[22,23]. Mertz et al. have shown that the inclusion of athroat swab increased the sensitivity of detection among
S. aureus carriers by 25.7% [22].
In this study, we showed that inclusion of throat and/
or peri-anal swabs increased the sensitivity of NAG
screening by 20%. The inclusion of additional swabs
could be especially important for HIV positive patients,
as unrecognized carriers can serve as reservoirs for
transmission during frequent hospital visits. Chow et al.
found that the inclusion of additional perianal and throat
swabs increased MRSA detection by 12.5% in HIV posi-
tive patients [24].
Our finding that recent diagnosis of lymphoma was
associated with MRSA colonization could be explained
by the increased likelihood for lymphoma in advanced
HIV infection when there is a greater extent of immuno-
suppression [25-27]. Some studies have shown an associ-
ation between MRSA colonization and cutaneous T-cell
lymphoma but not among HIV patients [28,29]. Simi-
larly, we identified low CD4 count as a risk factor for
MRSA colonization; this has been described in other
studies among HIV-positive patients [13,30,31].
Although univariate analysis showed an association be-
tween MRSA colonization and hospitalization within the
past year, this effect was negated in multivariate analysis.
Recent hospitalization has been frequently described as
a predictor for MRSA colonization among HIV-positive
patients in the published literature [14,15]. Interestingly,
in this study, we found a strong association between
MRSA colonization and previous hospitalization history
of household members. Studies have shown that family
members of colonized patients are at risk for MRSA
colonization and subsequent MRSA infection for many
months [7,32,33].
The association between MRSA colonization and the
presence of a percutaneous device within the past year
in this study was significant. Onorato and colleagues
found a seven-fold increased risk between the insertion
of a central venous catheter and MRSA colonization
among HIV-positive patients [14]. Both findings high-
light the importance of aseptic insertion and appropriate
care of such devices and may reflect that patients with
indwelling devices could have more contacts with
healthcare workers, making them more susceptible to
MRSA.
Our observation that receipt of ARV within the past
year was not associated with decreased risk of MRSA
colonization is inconsistent with previous studies [31].
We found strong association between age and MRSA
colonization. Studies have shown that elderly age (>65
years) is a risk factor for MRSA colonization despite pa-
tient group [24,34]. AUC value in our study showed that
predictors in the final model comprising six variables
can differentiate well between MRSA colonizers and
non-colonizers.
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predominantly male, and the sample size was small;
more independent risk factors may have been identified
with a larger study population. As our data were col-
lected at a single public hospital for only outpatients, it
may not reflect all HIV-infected patients. We may have
underestimated prior hospitalizations, as data collection
for this study did not account for admission to other
hospitals. Data collection was also limited for some risk
factors previously associated with MRSA colonization in
HIV infected patients such as prior incarceration and
high risk sexual behaviors [35,36]. Many healthcare
related factors assessed by the questionnaire in this
study may be subjected to recall and reporting bias.
However, this study highlights that a proportion of
MRSA carriers would have been undetected without
multiple-site screening cultures. HIV-positive patients
are at increased risk of MRSA colonization due to im-
munosuppression and also their exposure to healthcare
facilities.
Conclusions
This study highlights that a proportion of MRSA carriers
would have been undetected without multiple-site screen-
ing cultures. This study could shed insight into identifying
patients at risk of MRSA colonization upon hospital visit.
Predictors for MRSA colonization among HIV-positive
patients were age, history of bacterial pneumonia, lymph-
oma, presence of a percutaneous device within the past 12
months, history of household members hospitalized more
than two times within the past 12 months, and a most re-
cent CD4 count less than 200. This may suggest that a risk-
factor based approach for MRSA surveillance focusing on
high risk populations could be considered.
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